Clinical trial
The Metabolome Profiling and Pathway Analysis of ADHD
NCT02942225 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Metabolome Profiling and Pathway Analysis of ADHD
- Lead sponsor
- National Taiwan University Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 1, 2016
- Completion date
- March 19, 2020
- Enrollment
- 240 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
attention-deficit/hyperactivity disorder